US Stock MarketDetailed Quotes
ANTH Anthera Pharmaceuticals Inc
- 0.000001
- 0.0000000.00%
15min DelayClose Aug 21 16:00 ET
26.18Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000001Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)26.18MShares0.00800052wk High0.00P/B23.96Float Cap0.00000152wk Low--Dividend TTM23.96MShs Float581.120000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low--Avg Price1Lot Size
About Anthera Pharmaceuticals Inc Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life-threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy. The company was founded by Paul F. Truex on September 9, 2004 and is headquartered in Houston, TX.
Company Profile
SymbolANTH
Company NameAnthera Pharmaceuticals Inc
Issue Price7.00
Founded2004
MarketPink Market
Employees33
Fiscal Year Ends12-31
Address700 Milam,Suite 1300
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77002
Phone1-410-350-1839
Websitehttp://www.anthera.com
Company Executives
- Name
- Position
- Salary
- John Craig Thompson
- Director, Chief Executive Officer and President
- --
- May Liu, PhD
- Senior Vice President, Finance and Administration and Chief Accounting Officer
- --
- Paul F. Truex
- Executive Chairman of the Board
- --
- Brent F. Furse
- Director
- --
- Brian R. Mueller
- Independent Director
- --
- Dr. Christopher S. Henney, PhD
- Independent Director
- --
- David E. Thompson
- Independent Director
- --
- Dr. Philip T. Sager, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg